Samuel Funt, MD
Disclosures: Ownership Interest-Kite Pharma|Ownership Interest-Kronos Bio|Ownership Interest-Urogen Pharma|Contracted Research-Genentech, Inc.|Contracted Research-AstraZeneca|Ownership Interest-Allogene Therapeutics |Ownership Interest-Neogene Therapeutics|Ownership Interest-Vida Ventures
No Bio Available.